Log in

NASDAQ:VRNAVERONA PHARMA P/S SEC Filings & 10K Form

$4.72
-0.27 (-5.41 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.52
Now: $4.72
$4.97
50-Day Range
$4.25
MA: $4.94
$5.76
52-Week Range
$2.01
Now: $4.72
$12.89
Volume18,600 shs
Average Volume103,678 shs
Market Capitalization$62.14 million
P/E RatioN/A
Dividend YieldN/A
Beta0.1

SEC Filings

VERONA PHARMA P/S (NASDAQ:VRNA) SEC Filings

DateFilerForm TypeView
05/14/2020
8:24 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2020
6:34 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2020
1:57 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2020
2:32 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/06/2020
2:56 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2020
5:30 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2020
5:29 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2020
8:46 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2020
5:55 AM
VERONA PHARMA P/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/05/2020
5:46 AM
Andera Partners (Filed by)
VERONA PHARMA P/S (Subject)
Form SC 13G/A
02/04/2020
11:53 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2020
6:00 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2019
8:00 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2019
7:59 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2019
7:48 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2019
5:32 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2019
8:06 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2019
5:25 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2019
6:45 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2019
5:08 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2019
5:57 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2019
5:21 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
6:29 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2019
10:41 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2019
9:28 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2019
8:56 AM
Novo Holdings A/S (Filed by)
VERONA PHARMA P/S (Subject)
Form SC 13D
03/26/2019
6:01 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2019
5:38 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2019
11:42 AM
VERONA PHARMA P/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/12/2019
11:16 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2019
8:03 AM
Tekla Capital Management LLC (Filed by)
VERONA PHARMA P/S (Subject)
Form SC 13G/A
01/04/2019
1:12 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2018
8:24 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2018
8:27 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2018
12:46 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2018
5:35 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2018
10:27 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2018
11:15 PM
VERONA PHARMA P/S (Filer)
Form EFFECT
06/04/2018
8:39 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2018
3:19 PM
VERONA PHARMA P/S (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/08/2018
5:10 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2018
10:18 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2018
10:08 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2018
4:02 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2018
10:19 AM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2018
3:05 PM
VERONA PHARMA P/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2018
5:59 AM
VERONA PHARMA P/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/13/2018
11:11 AM
Foresite Capital Fund III, L.P. (Filed by)
VERONA PHARMA P/S (Subject)
Form SC 13G/A
02/06/2018
3:10 PM
Novo Holdings A/S (Filed by)
VERONA PHARMA P/S (Subject)
Form SC 13G/A
01/26/2018
3:55 PM
ORBIMED ADVISORS LLC (Filed by)
VERONA PHARMA P/S (Subject)
Form SC 13D/A
This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.